Cargando…

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy

Lung adenocarcinoma (LUAD) is a devastating disease with poor patient survival. Cancer immunotherapy has revolutionized the treatment of LUAD, but only a limited number of patients effectively respond to this treatment. Thus, the work to elucidate the LUAD immune heterogeneity could be crucial in de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yang, Yan, Shi, Fan, Weina, Zhang, Mengyan, Liu, Wei, Lu, Hailing, Cao, Mengru, Hao, Chenguang, Chen, Lin, Tian, Fanglin, Zhan, Yuning, Cai, Li, Xing, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348081/ https://www.ncbi.nlm.nih.gov/pubmed/32719796 http://dx.doi.org/10.3389/fcell.2020.00550

Ejemplares similares

LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer
por: Jia, Dexin, et al.
Publicado: (2021)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
por: Liu, Le-Ping, et al.
Publicado: (2021)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
por: Yang, Ronghua, et al.
Publicado: (2021)

Type 1 T Helper Cell-Based Molecular Subtypes and Signature Are Associated with Clinical Outcome in Pancreatic Ductal Adenocarcinoma
por: Wei, Ran, et al.
Publicado: (2022)

Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2022)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
por: Corral-Jara, Karla F., et al.
Publicado: (2021)

Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma
por: Zhang, Meng-Yu, et al.
Publicado: (2021)

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
por: Tian, Qi, et al.
Publicado: (2021)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
por: Hu, Rixin, et al.
Publicado: (2022)

The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
por: Liu, Xuefei, et al.
Publicado: (2022)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses
por: Hu, Fangjie, et al.
Publicado: (2021)

Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
por: Pan, Jingjing, et al.
Publicado: (2022)

A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma
por: Liu, Yuechao, et al.
Publicado: (2022)

Editorial: Autoimmunity, Infection and Cancer, an Inflammatory Relationship With Intimate Implication to Cancer Prevention and Immunotherapy
por: Chen, Zhibin, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022)

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis
por: Wang, Zihao, et al.
Publicado: (2020)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
por: Ouyang, Wenhao, et al.
Publicado: (2022)

An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy
por: Li, Mengling, et al.
Publicado: (2023)

Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps
por: Quan, Jing, et al.
Publicado: (2022)

Function and clinical application of exosome—how to improve tumor immunotherapy?
por: Qin, Siwen, et al.
Publicado: (2023)

Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy
por: Deng, Zimu, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA
por: Zhang, Shuai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m1quriqrlbpp3oovvm1vti46es